CSIMarket Company Name, Ticker, Competitors, else..


Abbvie Inc   (NYSE: ABBV)
Other Ticker:  
 

Abbvie Inc

ABBV's Fundamental analysis



Looking into Abbvie Inc growth rates, revenue grew by 8.39 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 1098

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.43 %

Abbvie Inc 's net profit decreased by -6.05 % in first quarter of 2025 year on year, to $1,289 millions.

• More on ABBV's Growth


Abbvie Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbvie Inc realized cash reduction of $ -7.28 per share in trailing twelve-month period.
Company
78.68
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.73.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.


• More on ABBV's Valuation
 
 Total Debt (Millions $) 69,889
 Dividend TTM ($) 6.29 $
 Dividend Yield TTM (%) 3.56 %
 Revenue/Employee (TTM) $ 1,147,340
 Net Income/Employee (TTM) $ 84,060
 Receivable Turnover (TTM) 4.93
 Tangible Book Value (Per Share $) -52.09

Abbvie Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbvie Inc realized cash outflow of $ -7.28per share in trailing twelve-month period.
Company
78.68
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.73.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.

Abbvie Inc Price to Book Ratio is at 224.82 higher than Industry Avg. of 34.08, and higher than S&P 500 Avg. of 0.01

• More on ABBV's Valuation

•  Market Capitalization (Millions $) 328,688
•  Shares Outstanding (Millions) 1,772
•  Employees 50,000
•  Revenues (TTM) (Millions $) 57,367
•  Net Income (TTM) (Millions $) 4,203
•  Cash Flow (TTM) (Millions $) -12,892
•  Capital Exp. (TTM) (Millions $) -1,016
•  Total Debt (Millions $) 69,889
•  Dividend TTM ($) 6.29 $
•  Dividend Yield TTM (%) 3.56 %
•  Revenue/Employee (TTM) $ 1,147,340
•  Net Income/Employee(TTM) $ 84,060
•  Receivable Turnover Ratio (TTM) 4.93
•  Tangible Book Value (Per Share $) -52.09

•  Market Capitalization (Millions $) 328,688
•  Shares Outstanding (Millions) 1,772
•  Employees 50,000
•  Revenues (TTM) (Millions $) 57,367
•  Net Income (TTM) (Millions $) 4,203
•  Cash Flow (TTM) (Millions $) -12,892
•  Capital Exp. (TTM) (Millions $) -1,016


    ABBV's Profitability Comparisons
Abbvie Inc achieved increase in profitability, due to cost control. Operating Margin grew in first quarter of 2025 to 27.98 %.

Abbvie Inc net profit margin of 9.66 % is currently ranking no. 38 in Major Pharmaceutical Preparations industry, ranking no. 98 in Healthcare sector and number 1241 in S&P 500.


Profitability by Segment
Total 9.66 %



  Ratio
•   Capital Ratio (MRQ) 0.76
•  Total Debt to Equity (MRQ) 47.8
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.41
•  Inventory Turnover Ratio (TTM) 3.87



Abbvie Inc achieved increase in profitability, due to cost control. Operating Margin grew in first quarter of 2025 to 27.98 %.

Abbvie Inc net profit margin of 9.66 % is currently ranking no. 38 in Major Pharmaceutical Preparations industry, ranking no. 98 in Healthcare sector and number 1241 in S&P 500.

• More on ABBV's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com